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Objective: Dentinal hypersensitivity is a commonly encountered problem with varied treatment options for its ma-
nagement. A large number of home use products have been tested and used for the management of dentinal hyper-
sensitivity. This 8 week clinical trial investigates the temporal efficacy of commercially available calcium sodium 
phosphosilicate containing toothpaste in comparison to a potassium nitrate containing toothpaste.
Methods: A total 20 subjects between the ages of 18 to 65 years were screened for a visual analogue score (VAS) for 
sensitivity of 5 or more by testing with a cold stimulus and randomly divided into test and positive control groups. 
Baseline sensitivity VAS scores to air evaporative stimulus were recorded for minimum two teeth. The subjects 
were prescribed respective dentifrices and revaluated for sensitivity scores at 2, 4 and 8 weeks.
Results:The study demonstrated reduction in symptoms for all treatment groups from baseline to 2, 4 and 8 weeks. 
The calcium sodium phosphosilicate group showed a higher degree of effectiveness at reducing hypersensitivity to 
air evaporative stimulus at 2 weeks, than commercially available potassium nitrate. However, there was no signifi-
cant difference in scores of subjects using the calcium sodium phosphosilicate toothpaste as compared to potassium 
nitrate at 4 weeks and 8 weeks. 
Conclusion: Calcium sodium phosphosilicate showed greater reduction in sensitivity compared to potassium nitra-
te at an earlier stage which is of high clinical value. However, based on the findings of the present study long term 
effects of calcium sodium phosphosilicate seem to be less promising than previously claimed.
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Introduction
Dentine hypersensitivity (DH) is the term used to des-
cribe common, painful condition of the permanent teeth; 
the etiology of which, however, is still poorly understo-
od and the various mechanisms have been proposed to 
explain the development of dentinal hypersensitivity and 
treatment alternatives have been reviewed (1-2). Most 
accepted of these is the hydrodynamic theory which was 
first explained by Gysi in 1900 and the experimental evi-
dence for which was provided by Bränström. According 
to this theory, the movement of dentinal fluid on stimu-
lation with thermal, chemical, evaporative or electric 
stimulus is responsible for excitation of the underlying 
dentinal mechanoreceptor resulting in sensitivity. Thus 
many treatment options aim at achieving dentinal tubule 
occlusion to prevent dentinal fluid movement, thereby 
reducing hypersensitivity.
The difficulty found in treating DH is expressed by the 
enormous number of techniques and therapeutic alter-
natives to relieve it (3). Several methods and materials 
have been tried to reduce dental sensitivity, ranging from 
home-use, over the counter products such as desensiti-
zing mouthwashes, dentifrices or tray application foams 
to in-office application products such as varnishes, li-
ners, restorative materials, dentinal adhesives iontopho-
resis procedures and more recently, lasers.
- Home use products- dentifrices
The home use products are most realistic and practical 
means of treating most patients with mild to modera-
te dentine hypersensitivity and they generally form the 
first step in routine management. Among these, desensi-
tizing dentifrices have established themselves as princi-
pal home care therapeutic agents owing to the fact that 
they are readily and widely available, cost effective, 
simple to use and non-invasive and the habit of tooth 
brushing being almost universal (4). A large number of 
agents have been shown to reduce the tubule diameter 
by precipitation of crystals and also shown to be clini-
cally efficacious. 
- Potassium nitrate
Potassium nitrate containing dentifrices have consis-
tently shown benefit in alleviating the hypersensitivity 
symptoms (5-7). They mainly act by blocking the neural 
transmission. A review by Kanapka concluded that po-
tassium nitrate use reduces hypersensitivity in 8-12wee-
ks (8). 
However as Porto et al. (3) have pointed out that in spite 
of a large amount of literature it is not possible to rea-
ch a consensus about a product that represents the gold 
standard in the treatment of dentinal hypersensitivity. 
Nevertheless, a large number of commercially available 
dentifrices consist of potassium nitrate.
- NovaMin technology
NovaMin was developed in the 1990s as a modification 
of bioactive glass which then had proven to be useful in 
bone regeneration and repair. It was found that NovaMin 
also reacted with the tooth dentin and was modified by 
grinding the particles, to obtain particles that were small 
enough to access the dentinal tubules. Each microscopic 
NovaMin particle serves as a delivery system for these 
ionized bioactive particles.
When the particle is exposed to fluid: saliva or tap water, 
it instantly reacts, releasing mineral ions of calcium (Ca) 
and phosphate (PO4) that augment the natural reminerali-
zation process. As the particle reactions continue and the 
deposition of Ca and PO4 complexes continue, this layer 
crystallizes into hydroxycarbonate apatite which is che-
mically and structurally equivalent to biological apatite. 
The combination of the residual NovaMin particles and 
the newly formed hydroxycarbonate apatite layer results 
in the physical occlusion of dentinal tubules, which will 
relieve hypersensitivity. In-vitro analyses have shown 
significant occlusion of tubules with the NovaMin com-
pounds (9, 10).
Each NovaMin bioglass particle is made of Calcium so-
dium phosphosilicate with 25% sodium, 25% calcium, 
6-8% phosphate and remainder, silica.
Previous studies (10-12) have shown clear benefit of 
NovaMin containing dentifrice over controls. Also a re-
cent review (13) concluded that the data look promising, 
but more research is needed.
The present study intends to compare the temporal effi-
cacy of a calcium sodium phosphosilicate containing 
toothpaste (Vantej® Dr Reddys’s Labs, Hyderabad, In-
dia) with potassium nitrate (Sensodent-K®, Warren Phar-
maceuticals, Mumbai, India) containing tooth-paste both 
of which are commercially available.
Material and Methods
This study was a single center, randomized, double blind 
and parallel group clinical trial. It was conducted in De-
partment of Periodontics at this institution in accordan-
ce with the Declaration of Helsinki and Guidelines for 
Good Clinical Practice.
The study duration was 8 weeks, in which sensitivity 
scores were measured at baseline, at 2 weeks, 4 weeks 
and at 8 weeks. After ethical approval, subjects were se-
lected from the outpatient section of the Department of 
Periodontics. Duration of the study was from October 
2009 to August 2010. 
- Inclusion Criteria:
Patients need to have at least two sensitive perma-1. 
nent tooth surfaces (buccal/facial aspects of incisors, 
canines or pre-molars). 
Sensitive tooth surfaces are selected if they have 2. 
wasting diseases and/or gingival recession.
No history of periodontal therapy in the past one 3. 
year.
- Exclusion Criteria:
Presently on desensitizing treatment.1. 
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distance of 1 to 3 mm from the exposed dentin surface 
of the test teeth which were duly isolated while adjacent 
teeth were protected with gloved fingers. VAS scores 
were recorded at baseline.
Phase I periodontal therapy (scaling) was instituted for 
all the subject and patients were provided with the res-
pective dentifrice.
The subjects were instructed to brush for 5 minutes, twi-
ce daily throughout the period of their study and asked 
to refrain from consuming very hot, cold, sweet or sour 
food or drinks. Subjects were also directed to refrain 
from any other dentifrice or mouthrinse during the trial 
but were allowed to continue their normal oral hygiene 
practice. 
Assessment was performed again at 2, 4 and 8 weeks.
- Statistical analyses:
Mean VAS scores and mean± S.D. were calculated from 
individual scores from all subjects in a treatment group. 
Student paired t-test was used to find out the difference 
between baseline, 2 weeks, 4 weeks and 8 weeks sco-
res of each group. Mean scores were compared among 
groups at baseline, 2 weeks, 4 weeks and 8 weeks using 
One Way Analysis of Variance (ANOVA) to find out the 
difference between the test and control group with ba-
seline scores. The data of test and control group were 
compared between 2 weeks, 4 weeks and 8 weeks using 
Analysis of Co-Variance (ANCOVA) with baseline as 
covariate. The percentage reduction from baseline- 2 
weeks, baseline- 4 weeks and baseline to 8 weeks was 
compared between the two groups using Students unpai-
red t-test.
Results
- Baseline demographics: 
A total number of 20 subjects were followed up for a 
period of 8 weeks. An ANOVA of baseline sensitivity 
indicated no significant difference effects for the groups 
for air evaporative stimulus. Since the baselines cores 
for both groups were similar and did not show any signi-
ficant differences, these scores were used as a covariate 
for the ANCOVA.
Significant Improvement Compared to Baseline. 
Paired t-tests for each group were carried-out comparing 
sensitivity at time points two, four and eight weeks to 
baseline. The trend was increasing reductions in dentin 
hypersensitivity over time for both test and the positi-
ve control group over time. The percentage reduction 
in sensitivity scores was 40.34%, 57.98% and 75.63% 
Subjects with orthodontic appliances or bridge work 2. 
that may interfere with evaluation.
Medical (including psychiatric and pharmacothera-3. 
peutic) histories that may compromise study proto-
col.
Allergies.4. 
Systemic conditions which are etiologic/predispo-5. 
sing to dentinal hypersensitivity.
Eating disorders.6. 
Pregnancy or breast feeding.7. 
Any dental treatment which may have an effect on 8. 
the desensitizing agent being used.
Any other pathology.9. 
Known history of allergies to dentifrice contents.10. 
Systemically healthy subjects of both genders, between 
the ages of 18 to 65 years, who were well versed with the 
use of toothbrush and dentifrice for oral hygiene mainte-
nance, were considered for the study. 
Informed consent was obtained from the compliant sub-
jects after explaining the rationale and purpose of the 
study.
Diagnosis of dentinal hypersensitivity was based on 
patient’s primary complaint and detailed history of the 
same regarding subjects’ perception of sensitivity to 
thermal stimuli (hot or cold), sweet or sour foods, drinks 
and to tooth-brushing. Other causes of dental pain (ca-
ries, periodontal pain) were ruled out during clinical 
examination. Teeth included in the study had no caries 
restorations.
To assess tooth sensitivity, a cold pack test of sensitive 
areas was performed using ice application. Sensitivity 
was measured using a 10cm visual analog scale (VAS) 
score, with the score of 0cm being a no-pain response, 
score of 5cm was perceptible discomfort and a score of 
10 being extreme pain or discomfort (modification of 
Hurkissons VAS, 1974). The clinical examination and 
sensitivity tests were carried out by a single examiner.
The two toothpastes compared were commercially avai-
lable non-aqueous toothpaste containing 5% calcium 
sodium phosphosilicate (test) and commercially availa-
ble toothpaste containing 5% potassium nitrate (positive 
control). The present study employed a double blinding 
procedure to eliminate subjective bias. The brand names 
from the tubes were painted over with a uniform color 
by a third person.
Patients reporting a grading of 5 or more of at least 2 
teeth (buccal/facial aspects of incisors canines and pre-
molars) were included in the study and designated into 
Group 1, receiving the toothpaste containing 5% calcium 
sodium phosphosilicate (tube painted red), and Group 2 
receiving the toothpaste containing 5% potassium nitra-
te (tube painted black) .
Scoring of tooth sensitivity was carried out by using 
controlled air pressure, from a standard dental syringe 
ambient temperature, directed perpendicularly and at a 
Group Percentage re-
duction in sensi-








tivity scores at 8 
weeks
1 40.34% 57.98% 75.63%
2 24.79% 47.86% 64.96%
Table 1. Percentage Reduction in Sensitivity Scores.
e21
J Clin Exp Dent. 2013;5(1):e18-22. Calcium sodium phosphosilicate in dentinal hypersensitivity.
at 2, 4 and 8 weeks respectively for the test group and 
24.79%, 47.86% and 64.96%. at 2, 4 and 8 weeks res-
pectively for the positive control group (Table 1).
- Comparison between groups:
Using an ANCOVA, with data from two weeks, four 
and eight weeks as dependent variables and baseline va-
lues as covariates, the sensitivity scores demonstrated a 
significant difference among groups at a period of two 
weeks (p= 0.0207). However there was no significant 
difference between groups with respect to reduction of 
scores at 4 and 8 weeks (p values 0.1146 and 0.1152 
respectively) (Table 2).
Discussion
The objective of this study was to evaluate the tempo-
ral efficacy and safety of a new commercially available 
desensitizing dentifrice formulation containing calcium 
sodium phosphosilicate toothpaste (Vantej®) and compa-
re it to a commercially available potassium nitrate con-
taining toothpaste (Sensodent K®). 
Air evaporative stimulus was used to evaluate sensitivi-
ty as it can be easily controlled over isolated teeth and 
simulates the physiologic stimuli. Study duration for this 
trial was 8 weeks as is recommended by Holland et al. 
(14).
A review of literature by Gendreau et al. (15), based on 
randomized controlled clinical trials, support the use of 
NovaMin in toothpaste formulations in providing relief 
of pain from dentin hypersensitivity.
The results of the present study demonstrate reduction 
in symptoms for all treatment groups from baseline to 
2, 4 and 8 weeks for measures of sensitivity. There was 
a remarkable pattern toward reduction of DH with time 
for all the variables during the 8 weeks of active phase 
of the study independent of treatment groups. This is in 
agreement with the studies by Salian et al. (10), Pradeep 
and Sharma(12), Sharma et al.(16), West et al. (17) and 
by Litkowski and Greenspan (18).
The calcium sodium phosphosilicate group showed a 
higher degree of effectiveness at reducing hypersensi-
tivity, than commercially available potassium nitrate for 
sensitivity, to air evaporative stimulus at 2 weeks. This is 
in accordance with the results of previous studies which 
showed that calcium sodium phosphosilicate is more 
effective compared to potassium nitrate in reducing sen-
sitivity scores as measured using the visual analogue 
scale (10, 12, 16). Calcium sodium phosphosilicate too-
thpaste thus may show greater benefit at an early stage as 
compared to potassium nitrate (16) which is also advo-
cated in the pilot study by Narongdej et al. (19). 
A comparative study by Parkinson and Willson (20) 
concluded that calcium sodium phosphosilicate imparts 
significant level of dentinal occlusion with durable oc-
clusive deposits following four days of twice daily brus-
hing in vitro.
However in contrast to the above mentioned studies, 
there was no significant difference in scores of patients 
using the calcium sodium phosphosilicate toothpaste as 
compared to potassium nitrate at 4 weeks and 8 weeks. 
This could possibly be due to the fact that both the active 
agents have been supplied using dentifrice as a delivery 
vehicle and the excipient (non-active) agents in the den-
tifrice may serve to occlude dentinal tubules over time, 
though a previous study has failed to show tubule occlu-
sion with potassium nitrate containing dentifrice (10). 
Also this effect could be related to a natural decrease in 
dentin hypersensitivity overtime, or because of patient 
perception of a decrease in symptoms by virtue of par-
 Group
VAS scores Pre- to Post-Brushing Reduction in hyper-sensitivity scores
BL 2 weeks 4 weeks 8 weeks BL-2Weeks BL-4Weeks BL-8Weeks
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 5.95 0.83 3.55 1.04 2.50 0.82 1.45 0.96 2.40 0.84 3.45 0.83 4.50 0.82
2 5.85 0.53 4.40 0.88 3.05 0.80 2.05 0.90 1.45 0.83 2.80 0.92 3.80 1.06
% of reduction 
from baseline in 
Group 1
40.34* 57.98* 75.63* 40.34* 57.98* 75.63*
% of reduction 
from baseline in 
Group 2
24.79* 47.86* 64.96* 24.79* 47.86* 64.96*
F-value 0.1029 6.0082 2.7932 2.6004 0.0207 0.1146 0.1152
p-value 0.7521 0.0254* 0.1130 0.1252 0.0207* 0.1146 0.1152




Table 2. Summary of the pre- and post-brushing hypersensitivity scores for subjects who completed the clinical study.
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ticipation in a clinical trial, or may be due to placebo 
products actually providing some degree of relief from 
dentin hypersensitivity.
The 5% potassium nitrate toothpaste was used as a po-
sitive control in our study because it has proved to be 
clinically efficient in the treatment of DH (5-8). In our 
study, the potassium nitrate group showed significant 
percentage reduction in sensitivity scores but reduction 
compared to the calcium sodium phosphosilicate group 
was less at 2 weeks. However, it was found to be as 
effective as calcium sodium phosphosilicate after 4 and 
8 weeks.
The results of the present study may have to be extrapo-
lated with caution given the small sample size and lack 
of accounting for the placebo effect and the Hawthorne 
effect. Because calcium sodium phosphosilicate showed 
greater reduction in sensitivity compared to potassium 
nitrate at an earlier stage, the direct implication of the 
present investigation would be faster relief which is 
of great clinical importance, given the acute nature of 
dentinal hypersensitivity. Based on the findings of the 
present study, long term effects of calcium sodium phos-
phosilicate seem to be less promising than previously 
claimed.
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